אולנזאפין דקסל 5 מ"ג

Riik: Iisrael

keel: heebrea

Allikas: Ministry of Health

Toimeaine:

OLANZAPINE 5 MG

Saadav alates:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC kood:

N05AH03

Ravimvorm:

TABLETS

Manustamisviis:

PER OS

Valmistatud:

DEXCEL LTD

Terapeutiline rühm:

OLANZAPINE

Näidustused:

Acute and maintenance treatment of schizophrenia. Olanzapine is indicated for the management of the manifestations of psychotic disorders. Olanzapine is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder: in patients whose manic episodes has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: the combination of olanzapine with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Loa andmise kuupäev:

2012-05-01